Topiramate, sold under the brand name Topamax, carries several well-documented long-term side effects that can persist for months or years during treatment. The most common complaints from long-term users involve cognitive difficulties, kidney stones, tingling in the hands and feet, and metabolic changes that affect bone and blood chemistry. Many of these effects are dose-related, meaning higher doses bring greater risk, and most improve after the medication is stopped.
Cognitive Problems: Memory, Word-Finding, and Focus
Cognitive side effects are among the most frequently reported issues with topiramate, and they don’t necessarily fade with time. In a one-year follow-up study of epilepsy patients taking relatively low doses (50 to 100 mg per day), 44% reported cognitive problems after a full year of treatment. The specific deficits showed up on tests of working memory and verbal fluency, confirming what many patients describe in everyday life: trouble holding information in your head, struggling to find the right word mid-sentence, and a general feeling of mental sluggishness.
The most common cognitive complaints include impaired attention and concentration, memory gaps, slowed thinking, and word-finding difficulties. Some people describe this as “brain fog” or feeling mentally dull. These effects are dose-related, so lower doses tend to cause fewer problems. The encouraging finding is that cognitive function significantly improved after patients stopped taking topiramate, suggesting the drug doesn’t cause permanent brain damage in most cases.
Kidney Stones
Topiramate increases your risk of developing kidney stones, and this risk grows with higher doses and longer use. A large study published in the American Journal of Kidney Diseases found that topiramate users had a 57% higher risk of symptomatic kidney stone events compared to non-users. The risk was even more pronounced in younger adults: people under 39 had an 87% higher risk.
Topiramate promotes stone formation because it inhibits an enzyme in the kidneys that normally helps keep urine from becoming too acidic. This creates an environment where calcium-based stones are more likely to form. Staying well-hydrated is the single most practical thing you can do to reduce this risk. If you’ve had kidney stones before starting topiramate, that history is worth discussing with your prescriber, as your baseline risk is already elevated.
Metabolic Acidosis
Topiramate can lower your blood’s bicarbonate levels, essentially making your blood more acidic than it should be. This condition, called metabolic acidosis, usually develops early in treatment but can appear at any point. Chronic low-grade metabolic acidosis often doesn’t produce obvious symptoms, which makes it easy to miss without blood work. Over time, it can contribute to bone weakening, kidney stones, and reduced growth in children.
Current prescribing guidelines recommend monitoring bicarbonate levels during treatment, with more frequent checks if you have conditions like chronic kidney disease or frequent diarrhea that already put you at risk for acid-base imbalances.
Tingling and Numbness
Paresthesia, a tingling or “pins and needles” sensation in the hands, feet, or face, is extremely common with topiramate. It tends to be most noticeable when you first start the medication or after a dose increase. For many people, this sensation lessens over weeks to months as the body adjusts. Potassium supplementation may help alleviate tingling in some cases. While paresthesia is more of a nuisance than a danger, some long-term users find it never fully resolves at higher doses.
Weight Loss That May Not Last
Topiramate typically causes weight loss, which is why it’s sometimes prescribed off-label for weight management or included in combination weight-loss medications. On average, people lose about 5% to 7% of their starting body weight over six months when combining the drug with lifestyle changes. Higher doses tend to produce more weight loss but also more side effects.
The weight loss is largely driven by appetite suppression, and this effect can diminish over time. Loss of appetite and other side effects also limit how long many people can tolerate the medication. If you stop taking topiramate, weight regain is common because the appetite-suppressing effect disappears.
Slowed Growth in Children
Children taking topiramate long-term may grow more slowly than expected. A study tracking children on topiramate monotherapy for three years found that growth rates fell below population norms, particularly between the first and second year of treatment. Children aged 6 to 9 and those aged 10 to 15 both showed slower-than-expected height gains, with minimal recovery by the third year. Girls appeared to be at somewhat higher risk for growth-related effects and weight loss. This is an important consideration for pediatric patients, since the growth window is limited and lost height velocity may not be fully recovered.
Eye Problems
Topiramate can trigger a rare but serious eye condition where pressure builds inside the eye, causing sudden blurred vision, eye pain, and redness. This typically happens within the first two weeks of starting the medication, not after years of use, but it’s important to recognize because delayed treatment can cause permanent vision damage. Patients with this reaction often experience a dramatic shift toward nearsightedness, sometimes severe. The condition resolves when topiramate is stopped promptly.
Risks During Pregnancy
One of the most significant long-term concerns with topiramate involves pregnancy. Growing evidence links topiramate exposure during pregnancy to neurodevelopmental problems in children. A population-based study of 246 exposed pregnancies found a 2.8-fold increased risk of autism spectrum disorder and a 3.5-fold increased risk of intellectual disability, particularly at doses above 100 mg per day. A separate study found a 2.4-fold increased risk of ADHD in topiramate-exposed children.
In a smaller observational study of 21 children exposed to topiramate in the womb, nearly one in five (19%) had autism, far above the general population rate, and higher doses were associated with worse adaptive functioning. These findings prompted the European Medicines Agency in 2023 to recommend that topiramate not be used during pregnancy unless no alternative exists, and to establish a pregnancy prevention program for women of childbearing age taking the drug.
What Happens When You Stop
Stopping topiramate after long-term use requires a gradual taper rather than abrupt discontinuation. Withdrawal symptoms can include irritability, mood swings, anxiety, insomnia, headaches, fatigue, nausea, and worsened brain fog. For people taking topiramate for seizure control, stopping suddenly can trigger breakthrough seizures, which is potentially dangerous. A prescriber will typically reduce the dose in stages over several weeks, giving the brain time to readjust.
The reassuring pattern across most side effects is reversibility. Cognitive problems, tingling, and metabolic changes generally improve after discontinuation. Kidney stone risk returns toward baseline once the drug is cleared. The main exceptions are effects that occurred during a critical window, such as fetal exposure during pregnancy or growth disruption in children, where the consequences may be lasting.